Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
MS in tijden van COVID-19
mei 2021 | Multipele Sclerose, Vaccinatie, Virale infecties